IBRX
ImmunityBio, Inc.
NASDAQ · USHealthcareBiotechnology
$7.50-2.41%
Price as of Jul 20, 2026
IBRX capital
ImmunityBio, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -1.29x
- Net debt / equity
- -1.06x
- Debt / assets
- 1.74x
- Debt / EBITDA
- -1.55x
- Net debt / EBITDA
- -1.27x
Liquidity & coverage
- Current ratio
- 6.67x
- Quick ratio
- 6.66x
- Cash ratio
- 5.61x
- Interest coverage
- -2.33x
- EBITDA / interest
- -6.48x
- Working capital
- $385.0M
Cash & dividend
- FCF / debt
- -0.27x
- Cash flow / debt
- -0.26x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.